Cargando…
Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptors
INTORDUCTION: Chondroitin sulfate proteoglycan 4 (CSPG4), also known as high molecular weight-melanoma associated antigen, is expressed in melanoma but also other tumor entities and constitutes an attractive target for immunotherapeutic approaches. While recent preclinical reports focused on anti-CS...
Autores principales: | Kropp, Korbinian N., Fatho, Martina, Huduti, Enes, Faust, Marilena, Lübcke, Silke, Lennerz, Volker, Paschen, Annette, Theobald, Matthias, Wölfel, Thomas, Wölfel, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577170/ https://www.ncbi.nlm.nih.gov/pubmed/37849763 http://dx.doi.org/10.3389/fimmu.2023.1245559 |
Ejemplares similares
-
HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model
por: Schrörs, Barbara, et al.
Publicado: (2017) -
A bicistronic vector backbone for rapid seamless cloning and chimerization of αβT-cell receptor sequences
por: Kropp, Korbinian N., et al.
Publicado: (2020) -
Stefanie Elisabeth Böning *07.07.1977 – † 01.01.2011
Publicado: (2011) -
Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice
por: El Bissati, Kamal, et al.
Publicado: (2020) -
Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8(+) T cells
por: Schlott, Fabian, et al.
Publicado: (2018)